. 1959 Jan;77(1):117–118. doi: 10.1128/jb.77.1.117-118.1959
THYMINE-REQUIRING VARIANT OF LACTOBACILLUS CASEI1
Aaron H Anton
a,2, Charles A Nichol
a,3
Aaron H Anton
aDepartment of Pharmacology, Yale University School of Medicine, New Haven, Connecticut
Find articles by Aaron H Anton
Charles A Nichol
aDepartment of Pharmacology, Yale University School of Medicine, New Haven, Connecticut
Find articles by Charles A Nichol
aDepartment of Pharmacology, Yale University School of Medicine, New Haven, Connecticut
2
Predoctoral Fellow of the American Foundation for Pharmaceutical Education. Present address: Department of Pharmacology and Therapeutics, College of Medicine, University of Florida, Gainesville, Florida.
3
Present address: Department of Experimental Therapeutics, Roswell Park Memorial Institute, Buffalo 3, New York.
1
This investigation was supported, in part, by a research grant (CE-2670) from the National Cancer Institute, U. S. Public Health Service.
PMCID: PMC290327 PMID: 13620661